Mario Negri Institute   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Milan Italy (1961)

Organization Overview

First Clinical Trial
1994
NCT00003053
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Consorzio Mario Negri Sud | Department of Immunology and Clinical Transplantation / Mario Negri Institute for Pharmacological Research and Ospedali Riuniti BG | Department of Immunology and Clinical Transplantation/Mario Negri Institute for Pharmacological Research and Ospedali Riuniti of Bergamo | Doctor Negrin University Hospital | Dr. Negrin University Hospital | Dr. Negrin University Hospital, Las Palmas | Fondazione Mario Negri Sud | Giovanni FM Strippoli, MD | Hospital Dr. Negrin de la Palmas | Hospital Universitario de Gran Canarias Dr. Negrin | Hospital Universitario Dr. Negrin | IRCCS Istituto di ricerche farmacologiche Mario Negri di Milano | Istituto de Ricerche Farmacologiche Mario Negri | Istituto Di Ricerche Farmacologiche Mario Negri | Istituto di Ricerche Farmacologiche Mario Negri IRCCS | Laboratory of Clinical Epidemiology of Cardiovascular Disease Department of Clinical Pharmacology and Epidemiology Consorzio Mario Negri Sud Via Nazionale 8/A S. Maria Imbaro (Chieti), 66030 ITALY | María de los Ángeles Tena Pajuelo | Mario Negri Gynecologic Oncology | Mario Negri Gynecologic Oncology group (MANGO) | Mario Negri Gynecologic Oncology group (MaNGO) Italy | 'Mario Negri' Institute for Pharmacological Research | Mario Negri Institute for Pharmacological Research | Mario Negri Institute for Pharmacological Research, Milan, Italy | Mario Negri Institute for Pharmacological Research Milano (Italy) | Mario Negri Institute for Pharmacological Research, Ranica BG | Mario Negri Institute for Phrmacological Research | Mario Negri Institute (IRFMN) | Mario Negri Institute, Milan, Italy | Mario Negri Institute of Pharmacological Research - IRCCS